Financial Statements
EX-10.2 3 c91654exv10w2.htm EXHIBIT 10.2 Exhibit 10.2 
Exhibit 10.2
| AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 11. CONTRACT ID CODE L page OF PAGES i I 3 2. AMENDMENT/MODIFICATION NO:13. EFFECTIVE DATE k REQUISITION/PURC15. PROJECT NO. (If applicable) See block 16CN/A N/A 6. ISSUED BYCODE |7. ADMINISTERED BY (If other than Item 6) CODE] Biomedical Advanced Research and Development Authority U.S. Department of Health and Human Services 330 Independence Avenue, SW Room G640 Washington, DC 20201 8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code) |_[9A. AMENDMENT OF SOLICITATION NO. BioCryst Pharmaceuticals, Inc. 9B. dated (see itemu) 2190 Parkway Lake Drive Birmingham, AL 35244 DUNS ###-###-#### TIN 62-1413174 10A.MODIFICATION OF CONTRACT/ ORDER X HHSO100200700032C 10B. DATED (SEE ITEM 13) C0DE .. FACILITY CODE 01-03-07 11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS The above numbered solicitation is amended as set forth In Item 14. The hour and date specified for receipt of Offers ~ is extended, ~ is not extended ?5ffea^urlkn°Wled9e feCeiPt °f th’S amend™2!prior t0 the nour and date spscmed In (he solicitation or as amended, by one of the following methods: (a) By completing Items 8 and 1^21 ^ ¦ T^ 1 7~^ °f thS amendmenl: W By acknowledging receipt of this amendment on each copy of the offer submitted- oV c By separate letter SSEE^ S 3 referenCe t0 the sollcitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT VhE PL^CE nT™TPn mo 12.ACCOUNTING AND APPROPRIATION DATA (If required)~~ ............. SOCC: ............ DOC# ............. TIN# ............. LOC# CAN# 13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS; IT MODIFIES THE CONTRACT/ORDER NO AS DESCRIBED IN ITEM 14. THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A. a! THIS CHANGE ORDER IS ISSUED PURSUANT TO: ~ |
| FAR 52.243-2 (Aug-87) Changes — Cost Reimbursement, Alternate V (Apr 1984) & FAR 52.245-4 (May-04) Government Property (Cost-Reimbursement, Time and Material, or Labor-Hour Contract) * THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes Inpayinq office- appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b). THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF: OTHER (Specify type of modification and authority) ~~ E. IMPORTANT: Contractor Q is not, [X] is required to sign this document and return 2 copies to the issuing office. 14. DESCRIPTION OF MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible) “ PURPOSE; The purpose of this modification is to: 1. Incorporate delivery of 18,000 vials of peramivir for possible emergency use as described in the attached pages of this modification. 2. The total contract amount remains unchanged at $179,852,147. The contract completion date remains unchanged. (December 31, 2011) Except as provided herein, all terms and conditions referenced in Item 9A or 10A, remain in full force and effect 15A. NAME AND TITLE OF SIGNER (Type or print) 116A. NAME AND TITLE OF CONTRACTS OFFICER (Type or print, :. .............................. Schuyler T. Eldridge 15B.CONTRACTOR/OFFEROR 115C. DATE SIGNED 16B. UNITED STATES OF AMERICA116C. DATE SIGNED —— ................ , ..................... , BY ISignature of person authorized to sign) \ ..................... [, (Signature of Contracting Officer)\ NSN 7540-01-152-8070 OMB No. 0990-0115 STANDARD FORM 30 (REV. 10-83) |
